News: Indonesia

The 2022 Indonesian Nutritional Status Survey (SSGI) shows that the national prevalence of stunting has decreased to by 2.8% to 21.6% compared to the previous year. Dexa Group collaborates with the National Population and Family Planning Board (BKKBN), the Indonesian National Police (Polri), and the Regional Government (Pemda) of Wonosobo…

Dexa Group is committed to supporting government programs to increase the use of domestic pharmaceutical products to achieve health resilience and independence. For this reason, the Ministry of Health presented three awards to Dexa Group at the National Forum for Down Streaming and Increasing the Use of Domestic Pharmaceutical Products…

STIMUNO, as the first phytopharmaca immunomodulator in Indonesia that has been clinically tested, maintains the end-to-end halal production process to provide comfort and safety for all Indonesian families. STIMUNO has also been declared safe by the Indonesian Food and Drug Authority (BPOM) through letter number B-PW.02.04.4.43.12.22.991. STIMUNO's positive progress, which…

Research from the International Journal of Cardiovascular Science reveals that moderate intensity and duration of physical activity support the immune response and increase the body's resistance to disease. This is important in the midst of an increasing trend of COVID-19 cases. For this reason, Oxyvit collaborated with the Indonesian Respiratory…

Amidst the rising trend of COVID-19, the Indonesian government predicts the number of travelers this year will increase by 50% compared to last year. Dexa Medica, as the national pharmaceutical research company, supports the health and well-being of travelers through the "Mudik Bareng Stimuno" campaign by distributing free vitamins, supplements,…

The President of the Republic of Indonesia (RI) Mr. Joko Widodo appreciated and encouraged the use of Indonesia Indigenous Modern Medicine (OMAI) in the National Health Insurance (JKN). This was conveyed during a visit to the Dexa Group booth with the theme OMAI Fitofarmaka at the Business Matching Exhibition for…

The Indonesian Pharmaceutical Companies Association (GP Farmasi) held an interactive dialogue entitled "Safe Medicinal Syrups for Children". It was revealed that the requirement for safe syrup preparations is in accordance with the provisions of the Food and Drug Administration (BPOM). "BPOM in conducting evaluations, in issuing permits, many standards are…

Dexa Group Wins Public Relations Indonesia Awards 2023 After going through a gradual judging process and presenting proposals, Dexa Group's Corporate Communications is considered to have a significant and positive impact on Public Relations (PR) performance throughout 2022. For this achievement, Dexa Group has won the highest award at the…

For his leadership that has allowed the company to adapt successfully, make breakthroughs, and continue to make developments to provide a positive stimulant to the economy in Indonesia, Dexa Group CEO Mr. Ferry Soetikno was awarded the Indonesia Most Acclaimed CEO 2022 in the pharmaceutical category from WartaEkonomi.co. id. Indonesia…

As a pioneer in the implementation of research for the Indonesia Indigenous Modern Medicine (OMAI) products certified by the Halal Product Assurance System, Dexa Group has achieved the Indonesia Halal Industry Award (IHYA) 2022 for the Best Halal Innovation category. The award held by the Ministry of Industry of the…